General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty

Orthopedics

Volumn 22, Issue 2, 1999, Pages 207-211

  Hofmann, S ^a   Trnka, H J ^b   Metzenroth, H ^b   Frank, E ^c   Ritschl, P ^b   Salzer, M ^c  

^a DANUBE HOSPITAL   (Austria)

^b Orthopedic Clinic Gersthof   (Austria)

^c Herz Jesu Hospital   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; RANITIDINE;

ADULT; AGED; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HETEROTOPIC OSSIFICATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RADIOTHERAPY; TOTAL HIP PROSTHESIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INDOMETHACIN; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; PREMEDICATION; PROSPECTIVE STUDIES; RANITIDINE; REOPERATION; SEVERITY OF ILLNESS INDEX;

EID: 0032995667     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Arcq M. Die paraartikularen Ossifikationen - eine Komplikation der Totalendoprothese der Hüfte. Archiv für Orthopädie und Unfallchirurgie. 1973; 77:108-131.
2. Ritter MA, Vaughan RB. Ectopic ossification after total hip arthroplasty. J Bone Joint Surg Am. 1977; 59:345-351.
3. Morrey BF, Adams RA, Cabanela ME. Comparison of heterotopic bone after anterolateral, transtrochanteric, and posterior approaches for total hip arthroplasty. Clin Orthop. 1984; 188:160-167.
4. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement. Incidence and method of classification. J Bone Joint Surg Am. 1986; 55:1629-1632.
5. Goel A, Sharp DJ. Heterotopic bone formation after hip replacement. J Bone Joint Surg Br. 1991; 73:255-257.
6. Kjaesgaard-Andersen P, Schmidt St A. The role of antiinflammatory medications in the prevention of heterotopic ossification. Clin Orthop. 1991; 263:78-86.
7. Kjaesgaard-Andersen P, Ritter MA. Current concepts review, prevention of formation of heterotopic bone after total hip arthroplasty. J Bone Joint Surg Am. 1991; 73:942-947.
8. Naraghi FF, DeCoster TA, Moneim MS, Miller RA, Rivero D. Heterotopic ossification: review. Orthopaedics International Edition. 1996; 4:131-141.
9. Riska EB, Michelson J-E. Treatment of para-articular ossification after total hip replacement by excision and use of free fat transplants. Acta Orthop Scand. 1979; 50:751-754.
10. Abrahamson S-O, Ahigren A-A, Dahlström JA, Ohlin P, Stigson L. Ectopic bone after hip replacement. Acta Orthop Scand. 1984; 55:589-592.
11. Ayers DC, Evarts McC, Parkinson JR. The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip arthroplasty. J Bone Joint Surg Am. 1986; 68:1423-1430.
12. Healy WL, Lo TC, Covall DJ, Pfeifeer BA, Wasilewski St A. Single-dose radiation therapy for prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty. 1990; 5:369-375.
13. Eyb R, Knahr K. The effect of prophylaxis for thrombosis on heterotopic ossification following total hip joint replacement. Arch Orthop Trauma Surg. 1983; 102:114-117.
14. Schmidt St A, Kjaesgaard-Andersen P, Pedersen NW, Kristensen S, Pedersen P, Nielsen JB. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. J Bone Joint Surg. Am. 1988; 70:834-838.
15. Freiberg A, Cantor R, Freiberg RA. The use of aspirin to prevent heterotopic ossification after total hip arthroplasty. Clin Orthop. 1991; 267:93-96.
16. Ahrengart L. Periarticular heterotopic ossification after total hip arthroplasty. Clin Orthop. 1991; 263:50-58.
17. Gebuhr P, Wilbek H, Soelberg M. Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty. Clin Orthop. 1995; 314:166-169.
18. Ritter MA, Sieber JM. Prophylactic indomethacin for prevention of heterotopic bone formation following total hip arthroplasty. Clin Orthop. 1985; 196:217-225.
19. Nilsson OS, Bauer HC, Brosjö O, Törnkvist H. Influence of indomethacin on induced heterotopic bone formation in rats. Clin Orthop. 1986; 207:239-245.
20. Knahr K, Salzer M, Eyb R, Frank P, Blauensteiner W. Heterotopic ossification with total hip endoprosthesis in various models of thrombosis prophylaxis. Arthroplasty. 1988; 3:1-8.
21. Kristensen S, Pedersen P, Pedersen NW, Schmidt St A, Kjaesgaard-Andersen P. Combined treatment with indomethacin and low-dose heparin after THR. J Bone Joint Surg Br. 1990; 72:447-449.
22. Kjaesgaard-Andersen P, Ritter MA. Short-term treatment with nonsteroidal antiinflammato-ry medications to prevent heterotopic bone formation after total hip arthroplasty. Clin Orthop. 1992; 279:157-162.
23. Wurnig Ch, Eyb R, Auersperg V. Indomethacin for prevention of ectopic ossification in cementless hip arthroplasty. Acta Orthop Scand. 1992; 63:628-630.
24. McMahon JS, Waddell JP, Morton J. Effect of short-course indomethacin on heterotopic bone formation after uncemented total hip arthroplasty. Arthroplasty. 1991; 6:259-264.
25. Metzenroth H, Publig W, Knahr K, Zandl Ch, Kuchner G, Carda Ch. Osifikationsprophylaxe nach Hüfttotalendoprothesen mit Indomethacin und ihr Einfluβ auf die Magenschleimhaut. Z Orthop. 1991; 129:178-182.
26. Ijiri K, Matsunaga S, Fukuda T, Shimizu T. Indomethacin inhibition of ossification induced by direct current stimulation. Journal of Orthopaedic Research. 1995; 13:123-131.
27. Wurnig Ch, Auersperg V, Böhler N, et al. Short term prophylaxis against heterotopic bone after cementless hip replacement. Clin Orthop. 1997, 334:175-183.
28. Trancik T, Mills W, Vinson N. The effect of indomethacin, aspirin, and ibuprofen on bone ingrowth into a porous-coated implant. Clin Orthop. 1989; 249:113-121.
29. Coventry MB, Scanlon PW. The use of radiation to discourage ectopic bone. J Bone Joint Surg Am. 1981; 63:201-208.
30. Lo TCM, Healy WL, Covall DJ, et al. Heterotopic bone formation after hip surgery: prevention with single-dose postoperative hip irradiation. Radiology. 1988; 168:851-854.
31. Sumner DR, Turner TM, Pierson RH, et al. Effects of radiation on fixation of non-cemented porous-coated implant in a canine model. J Bone Joint Surg Am. 1990; 72:1527-1533.
32. Wise MW III, Robertson ID, Lachiewicz PF, Thrall DE, Metcalf M. The effect of radiation therapy on the fixation strength of an experimental porous-coated implant in dogs. Clin Orthop. 1990; 261:276-280.
33. Pellegrini VD Jr, Konski A, Gastel JA, Rubin P, Evarts CM. Prevention of heterotopic ossification with irradiation after total hip arthroplasty. J Bone Joint Surg Am. 1992; 74:186-200.
34. Pagnani MJ, Pellicci PM, Salvati EA. Effect of aspirin on heterotopic ossification after total hip arthroplasty in men who have osteoarthritis. J Bone Joint Surg Am. 1991; 73:924-929.
35. Kjaesgaard-Andersen P, Nafei A, Teichert G, et al. Indomethacin for prevention of heterotopic ossification. Acta Orthop Scand. 1993; 64:636-642.
36. Ahrengart L, Blomgren G, Tömkvist H. Short-term ibuprofen to prevent ossification after hip arthroplasty. Acta Orthop Scand. 1994; 65:139-141.
37. Dorn U, Grethen C, Effenberger H, Berka H, Ramsauer H, Drekonja T. Indomethacin for prevention of heterotopic ossification after hip arthroplasty: a randomized comparison between 4 and 8 days of treatment Acta Orthop Scand. 1998; 69:107-110.
38. Ayers DC, Pellegrini VD, Evarts MC. Prevention of heterotopic ossification in high-risk patients by radiation therapy. Clin Orthop. 1991; 263:87-93.
39. Fowble VA, Amstutz HC, Dorey FJ, Schmalzried TP. Effect of indomethacin on low-dose warfarin thromboembolic prophylaxis following total hip arthroplasty. Presented at the 63rd Annual Meeting of the American Academy of Orthopaedic Surgeons; February 22-27, 1996; Atlanta, Ga.
40. Jacobsson A-A, Djerf K, Ivarsson I, Wahlstrom O. Effect of diclofenac on fixation of hydroxyapatite-coated implant. J Bone Joint Surg Br. 1994; 76:831-833.